✦ LIBER ✦

Fragment-based discovery and optimization of BACE1 inhibitors

✍ Scribed by James Madden; Jenny R. Dod; Robert Godemann; Joachim Kraemer; Myron Smith; Marion Biniszkiewicz; David J. Hallett; John Barker; Jane D. Dyekjaer; Thomas Hesterkamp

Book ID: 104004562
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 710 KB
Volume: 20
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2010.06.089

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fragment-Based Discovery of Bromodomain

Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides

✍ Bamborough, Paul; Diallo, Hawa; Goodacre, Jonathan D.; Gordon, Laurie; Lewis, An 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 773 KB

Macrocyclic Statine-Based Inhibitors of

Macrocyclic Statine-Based Inhibitors of BACE-1

✍ Alessandra Barazza; Marion Götz; Sergio A. Cadamuro; Peter Goettig; Michael Will 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 696 KB

ChemInform Abstract: Fragment-Based Disc

ChemInform Abstract: Fragment-Based Discovery of JAK-2 Inhibitors.

✍ Stephen Antonysamy; Gavin Hirst; Frances Park; Paul Sprengeler; Frank Stappenbec 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views

Discovery of Plasmepsin Inhibitors by Fr

Discovery of Plasmepsin Inhibitors by Fragment-Based Docking and Consensus Scoring

✍ Ran Friedman; Amedeo Caflisch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

Fragment-Based Lead Discovery: Screening

Fragment-Based Lead Discovery: Screening and Optimizing Fragments for Thermolysin Inhibition

✍ Lisa Englert; Katrin Silber; Holger Steuber; Sascha Brass; Björn Over; Hans-Diet 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Discovery and optimization of nonpeptide

Discovery and optimization of nonpeptide HIV-1 protease inhibitors

✍ Peter J. Tummino; J.V.N. Vara Prasad; Donna Ferguson; Carolyn Nouhan; Neil Graha 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 779 KB

Several small, achiral nonpeptide inhibitors of HIV-1 protease with low micromolar activity were identified by mass screening of the Parke-Davis compound library. Two of the compounds, structurally similar, were both found to be competitive and reversible inhibitors [compound 1, 4-hydroxy-3-(3-pheno